Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2

• Mengwen Huang
• Xingchao Pan
• Jianfeng Chen

Letter 27 February 2023

Featured

• 

  The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation

  • Zhaolong Li
  • Pengfei Hao
  • Wenyan Zhang

  Article Open Access 03 Feb 2023
• 

  Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

  • Hai-Dong Zhu
  • Hai-Liang Li
  • for the CHANCE001 Investigators

  Article Open Access 08 Feb 2023
• 

  Molecular and functional imaging in cancer-targeted therapy: current applications and future directions

  • Jing-Wen Bai
  • Si-Qi Qiu
  • Guo-Jun Zhang

  Review Article Open Access 27 Feb 2023
• 

  Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization

  • Shao-bin Wang
  • Yosuke Nagasaka
  • Jayakrishna Ambati

  Letter Open Access 20 Feb 2023

Announcements

• 

  Behind the Paper

  In these Behind the Paper posts, our authors share the real stories behind the latest research papers, from conception to publication, the highs and the lows.

• Published in partnership with West China Hospital, Sichuan University

  

Advertisement

Browse articles

• 

  Promotion of liquid-to-solid phase transition of cGAS by Baicalein suppresses lung tumorigenesis

  • Tiansheng Zheng
  • Haipeng Liu
  • Lihong Fan

  Letter Open Access 22 Mar 2023
• 

  Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

  • Xin Peng
  • Yingying Wang
  • Dexin Kong

  Letter Open Access 22 Mar 2023
• 

  To metabolomics and beyond: a technological portfolio to investigate cancer metabolism

  • Federica Danzi
  • Raffaella Pacchiana
  • Alessandra Fiore

  Review Article Open Access 22 Mar 2023
• 

  FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection

  • Zhe Li
  • Shuai Wang
  • Fangfang Zhou

  Research Highlight Open Access 21 Mar 2023
• 

  TGF-β changes cyto/mito-ribosome balance to target respiratory chain complex V biogenesis in pulmonary fibrosis therapy

  • Na Zhang
  • Zunling Zhao
  • Yan Qin

  Letter Open Access 21 Mar 2023
• 

  Structural characteristics of the SARS-CoV-2 Omicron lineages BA.1 and BA.2 virions

  • Xiaoyu Ma
  • Yanqun Wang
  • Zheng Liu

  Letter Open Access 20 Mar 2023
• 

  Small molecule metabolites: discovery of biomarkers and therapeutic targets

  • Shi Qiu
  • Ying Cai
  • Aihua Zhang

  Review Article Open Access 20 Mar 2023
• 

  Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer

  • Xiuwen Guan
  • Fei Ma
  • Binghe Xu

  Letter Open Access 19 Mar 2023
• 

  ALYREF mediates RNA m⁵C modification to promote hepatocellular carcinoma progression

  • Chen Xue
  • Xinyu Gu
  • Lanjuan Li

  Letter Open Access 18 Mar 2023

Trending - Altmetric

• 

  Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines

• 

  SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy

• 

  A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.

• 

  Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•